Monoclonal Antibody
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
136
NCT07120503
Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma
Phase: Phase 2
Role: Lead Sponsor
Start: Jul 24, 2025
Completion: Oct 31, 2027
Loading map...